Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-16

FDA Approved: FOSAPREPITANT — Supplemental Application (Avenacy, LLC)

View source ↗

Summary

FDA approved a supplemental application for Fosaprepitant (fosaprepitant dimeglumine) from Avenacy, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

SUPPL AP for FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)